P016: Real-World Clinical Outcomes and Toxicity in Metastatic Breast Cancer Patients Treated With first or second line CDK 4/6 Inhibitors and Endocrine Therapy in Egypt
{"title":"P016: Real-World Clinical Outcomes and Toxicity in Metastatic Breast Cancer Patients Treated With first or second line CDK 4/6 Inhibitors and Endocrine Therapy in Egypt","authors":"A. Kortoma, H. El Wakeel, N. Gobran, H Elghazawy","doi":"10.1016/j.breast.2025.103909","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":9093,"journal":{"name":"Breast","volume":"80 ","pages":"Article 103909"},"PeriodicalIF":5.7000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breast","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0960977625000761","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
期刊介绍:
The Breast is an international, multidisciplinary journal for researchers and clinicians, which focuses on translational and clinical research for the advancement of breast cancer prevention, diagnosis and treatment of all stages.